- | Country :
- France
- | organs : -
- | Specialty : -
Extract
The objective of the trial is to evaluating the feasibility of dose increase by a boost of curietherapy in PDR (at least 40 Gy on D95) associated to extern radiotherapy (34 Gy) in intermediate risk in prostate cancer.
Inclusion criteria
- Prostate Cancer With Intermediate Risk